Friday 26 / April / 2024
Muscat: Two scientists from the Sultan Qaboos University have received a patent for a new method in the global battle against Human Immunodeficiency Virus (HIV).
The patent application for the invention was filed on August 25, 2017 and granted from the United States Patent Office (USPTO) on April 8, 2019.
The invention is a scientific and medical breakthrough which relates to a novel treatment for HIV/AIDS patients.
Dr. Sidgi Syed Anwar Abdo Hasson and Prof. Ali Abdullah Hasan Al Jabri from the Department of Microbiology and Immunology, College of Medicine and Health Sciences of SQU invented a ‘new formula for the eradication of HIV’ using a female camel as a life factory model to treat HIV/AIDS patients.
They said that their formula was the result of more than 16 years of research work involving a wide range of medico-scientific research disciplines with many challenges and disappointments.
The application process for the invention took almost three years, wherein the application was examined thoroughly by many scientific and medical committees outside SQU, and also by professional examiners from the United States Patent Office.
Both scientists have managed to invent, prepare and test a therapeutic formula using a female camel to treat HIV/AIDS patients with full eradication of HIV.
The therapeutic composition contains camel milk and other herbal compounds with “anti-HIV antibodies”.
The camel is immunised against different HIV strains by using DNA immunisation technology
The composition can be administered to a patient infected with HIV, or for the prevention of HIV infection.
After relentless research work, a clinical trial was performed to test the efficacy of the composition.
During and after the treatment, all human AIDS patients involved in the clinical trial, in the presence of numerous physicians and nurses, showed positive response with no side effects, and the symptoms of the patients were noticeably improved after a few weeks of starting the treatment. All patients regardless of their lifestyle, race, age and sex showed that their health significantly improved. According to the criteria of curative effect all cases were effective.
The patients who lost weight due to their ailment witnessed weight gain of up to 10 kgs after less than three months of treatment. In the treated group, most, if not all, of the symptoms of the cases showed improvement after taking the invented formula. This was also associated with immune function improvement. The new formula for all cases tested was found to be very effective to suppress HIV replication as well as to eradicate the virus from the patients.
This was confirmed after a for month screening of all patients involved in the trials.
“The idea of using camels to produce this is novel and we hope it will open new gates not only for the eradication and treatment of HIV infection but also for the eradication and prevention of infection with other viruses using the same concept. This is because the immune system of camels is well known to be much more effective than the human immune system”, the university reported in a statement. Infection of Human Immunodeficiency Virus (HIV) can lead to a patient getting Acquired Immunodeficiency Syndrome (AIDS).
AIDS is a major global health emergency, and is the sixth leading cause of death in the world and the third in low-income countries.
Currently there is a treatment for HIV/AIDS, however, it is not effective as it is associated with serious side effects; it is expensive and not accessible to all patients in need.
Dream of scientists
Thus there is a need for an effective HIV/AIDS treatment that is well tolerated by the human body, relatively inexpensive, and easily accessible. Moreover, currently there is no working vaccine or cure for HIV/AIDS. It is a dream for all scientists all over the world to discover a cure for HIV/AIDS and to eradicate HIV.
Dr. Sidgi Hasson and Prof. Ali Al-Jabri were involved in conducting research on HIV/AIDS for over 16 and 30 years, respectively.
Dr. Sidgi Hasson is a British Scientist, with a Ph.D from Liverpool School of Tropical Medicine, United Kingdom with vast experience in Molecular Immunology and DNA immunisation and Prof Al-Jabri is an Omani Scientist with a PhD from the Royal London School of Medicine and Dentistry, University of London.
Prof Al-Jabri also holds a Fellowship in Immunology from the Royal College of Pathologists, United Kingdom.
The scientists have contributed significantly to the global medical community by publishing many scientific peer reviewed papers in well-known journals on HIV/AIDS.
